About Respiri
Respiri is a company based in Melbourne (Australia) founded in 1987.. Respiri offers products and services including WheezeRate Detector, RPM Programs, and Telehealth Platforms. Respiri operates in a competitive market with competitors including Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others.
- Headquarter Melbourne, Australia
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vitasora Health Limited
-
Annual Revenue
$2.04 M (USD)580.63as on Jun 30, 2025
-
Net Profit
$-6.68 M (USD)-41.74as on Jun 30, 2025
-
EBITDA
$-7.04 M (USD)-40.59as on Jun 30, 2025
-
Latest Funding Round
$12.5 M (USD), Post-IPO
Oct 20, 2020
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Respiri
Respiri is a publicly listed company on the ASX with ticker symbol VHL in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Respiri
Respiri offers a comprehensive portfolio of products and services, including WheezeRate Detector, RPM Programs, and Telehealth Platforms. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
FDA-cleared device for remote detection of wheezes in patients.
Customizable programs for monitoring and managing chronic conditions remotely.
HIPAA-compliant platforms for data-driven patient care and interventions.
Unlock access to complete
Unlock access to complete
Funding Insights of Respiri
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $12.5M
-
First Round
First Round
(01 Oct 2011)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Post-IPO - Respiri | Valuation |
investors |
|
| Mar, 2020 | Amount | Post-IPO - Respiri | Valuation |
investors |
|
| Apr, 2018 | Amount | Post-IPO - Respiri | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Respiri
Respiri has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Bergen Asset Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Bergen Asset Management is focused on global institutional investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Respiri
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Respiri
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Respiri Comparisons
Competitors of Respiri
Respiri operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| domain | founded_year | HQ Location |
Medical devices for structural heart disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Vital signs are monitored via a single-use patch and platform.
|
|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
Provider of smart solutions for monitoring heart rate, weight, and blood pressure
|
|
| domain | founded_year | HQ Location |
Remote monitoring platform for tracking patient activity
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Respiri
Frequently Asked Questions about Respiri
When was Respiri founded?
Respiri was founded in 1987 and raised its 1st funding round 24 years after it was founded.
Where is Respiri located?
Respiri is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Who is the current CEO of Respiri?
Mario Gattino is the current CEO of Respiri.
What is the annual revenue of Respiri?
Annual revenue of Respiri is $2.04M as on Jun 30, 2025.
What does Respiri do?
Respiri was founded in 1987 in Melbourne, Australia, where tools for detecting respiratory disorders are developed. A range of clinical laboratory and home care products is created by the company within the medical technology sector. The SonoSentry system, an over-the-counter device for automated wheeze detection, is offered, with data upload capabilities to the cloud through a web portal. Leadership is provided by CEO and Director Mario Gattino.
Who are the top competitors of Respiri?
Respiri's top competitors include Tyto Care, Endotronix and Athelas.
What products or services does Respiri offer?
Respiri offers WheezeRate Detector, RPM Programs, and Telehealth Platforms.
Is Respiri publicly traded?
Yes, Respiri is publicly traded on ASX under the ticker symbol VHL.
Who are Respiri's investors?
Respiri has 1 investor. Key investors include Bergen Asset Management.
What is Respiri's ticker symbol?
The ticker symbol of Respiri is VHL on ASX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.